Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Stage II-III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00681928
What this trial is testing

Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy

Who this might be right for
Breast Cancer
City of Hope Medical Center 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129187
What this trial is testing

SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response

Who this might be right for
Early Breast CancerHER2 + Breast CancerStage II Breast Cancer+1 more
Chuan Wang 30
Large-scale testing (Phase 3)Study completedNCT00630032
What this trial is testing

Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 762
Large-scale testing (Phase 3)Not Yet RecruitingNCT06787118
What this trial is testing

Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III+2 more
Gustave Roussy, Cancer Campus, Grand Paris 130
Not applicableStudy completedNCT00376597
What this trial is testing

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

Who this might be right for
Lymphedema
Alliance for Clinical Trials in Oncology
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06179303
What this trial is testing

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Locally Advanced Unresectable HER2-Negative Breast Carcinoma+3 more
University of Washington 60
Testing effectiveness (Phase 2)Study completedNCT00675259
What this trial is testing

Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 33
Large-scale testing (Phase 3)Study completedNCT01099436
What this trial is testing

Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients

Who this might be right for
Breast Cancer
Borstkanker Onderzoek Groep 250
Testing effectiveness (Phase 2)UnknownNCT04398446
What this trial is testing

Effect of Hemp-CBD on Patients With CIPN

Who this might be right for
Chemotherapy-induced Peripheral NeuropathyColorectal Cancer Stage IIColorectal Cancer Stage III+4 more
Main Line Health 56
Testing effectiveness (Phase 2)UnknownNCT02115152
What this trial is testing

Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer

Who this might be right for
Stage II Breast CancerStage III Breast Cancer
Guangxi Medical University 100
Not applicableStudy completedNCT02751710
What this trial is testing

Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer

Who this might be right for
Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)Stage IIb Breast Cancer (T3N0)
Ontario Clinical Oncology Group (OCOG) 369
Large-scale testing (Phase 3)Active Not RecruitingNCT03927027
What this trial is testing

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III
Alliance for Clinical Trials in Oncology 534
Very early researchStudy completedNCT03411070
What this trial is testing

SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer

Who this might be right for
Positive Axillary Lymph NodeStage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7+9 more
Jonsson Comprehensive Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00003953
What this trial is testing

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT01750073
What this trial is testing

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+13 more
University of Nebraska 92
Not applicableEnded earlyNCT04862195
What this trial is testing

Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more
Blue Note Therapeutics 31
Large-scale testing (Phase 3)UnknownNCT05253066
What this trial is testing

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

Who this might be right for
Breast Neoplasms
Shengjing Hospital 130
Testing effectiveness (Phase 2)Looking for participantsNCT06806930
What this trial is testing

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III+1 more
George Washington University 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT00295893
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 121
Next Page